DF
Drug FarmDrug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.
2 Pulse stories
EM
Encore MedicalEncore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).
2 Pulse stories
Total Raised
$138M
Drug FarmEncore Medical
Last ValuationNot disclosed
Biotech
Sector
Biotech
2015
Founded
2017
Shanghai, China / New York, NY
HQ
Eagan, Minnesota
Private
Status
Public (EMI)
Drug Farm investors
Shanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity FundDetong CapitalWuXi AppTecBioVeda China FundYD CapitalBetta CapitalWedo Venture Management
Encore Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Drug Farm and Encore Medical.